Related Experiment Video
Updated: Jun 8, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Differential gene expression activity among species-specific polypyrimidine/polypurine motifs in mu opioid receptor
Chung-Youl Choe1, Jinping Dong, Ping-Yee Law
1Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455, USA. chungychoe@gmail.com
Abstract:
The mu opioid receptor (MOR) is the principle molecular target of opioid analgesics. An appropriate understanding of MOR gene expression across species is critical for understanding its analgesic functions in humans. Here, we undertake a cross-species analysis of the polymorphic polypyrimidine/polypurine (PPy/u) motif, a key enhancer of MOR gene expression. The mouse PPy/u motif is highly homologous to those of rat (67%) and human (83%), but drives reporter gene expression tenfold and fivefold more effectively than those of rat and human, respectively. Circular dichroism profiles of PPy/u oligonucleotides from different species showed that they are primarily different in structure. Conformational studies of reporter plasmids using confocal Raman spectra, S1 nuclease and restriction enzymes demonstrated that the structural difference is the result of changes in the phosphodiester backbone. Furthermore, these conformational disparities produce differences in torsional stress, as shown by topoisomerase II relaxation and activation of different levels of gene expression under hypertonic conditions. This study demonstrates that homologous PPy/u motifs adopt unique species-specific conformations with different mechanisms and activities for gene expression. We further discuss how structural aspects of transcription regulatory elements, rather than the sequence itself, are significant when studying functional gene expression regulatory elements.
Insights
Species-specific structures of the mu opioid receptor (MOR) gene enhancer (PPy/u motif) impact its expression. Structural differences, not just sequence, dictate gene regulation and opioid analgesic function.
Area of Science:
- Genetics
- Molecular Biology
- Pharmacology
Background:
- The mu opioid receptor (MOR) is a key target for opioid analgesics.
- Understanding MOR gene expression across species is crucial for human pain management.
Purpose of the Study:
- To investigate the cross-species variations in the PPy/u motif, a critical enhancer of MOR gene expression.
- To determine how structural differences in the PPy/u motif affect gene expression activity.
Main Methods:
- Comparative analysis of PPy/u motifs from mouse, rat, and human.
- Reporter gene assays to measure enhancer activity.
- Circular dichroism, confocal Raman spectroscopy, S1 nuclease, and restriction enzyme assays to study DNA structure.
- Topoisomerase II assays to assess torsional stress.
Main Results:
- Mouse PPy/u motif shows high homology but significantly higher reporter gene activity than rat and human motifs.
- Structural differences in PPy/u oligonucleotides, particularly in the phosphodiester backbone, were identified.
- Conformational disparities lead to varied torsional stress and differential gene expression levels.
Conclusions:
- Homologous PPy/u motifs exhibit unique, species-specific conformations that influence gene expression mechanisms and activity.
- The structural conformation of transcription regulatory elements is a significant factor in functional gene expression, beyond mere sequence homology.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
07:48Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
The Eukaryotic Promoter Region
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors